本日は、公益財団法人 東京都医学総合研究所 シナプス可塑性プロジェクト (山形要人プロジェクトリーダー)のラボから出版された「セロトニンは、海馬ニューロンのArcadlinを誘導する」という論文を勉強しました(紹介者：LJ)
Neuroscience Letters Volume 721, 16 March 2020, 134783
Serotonin induces Arcadlin in hippocampal neurons
Highlights
• Neural activity induces Arcadlin, which mediates the activation of p38 MAP kinase.
• Dual inputs by serotonin and glutamate induce Arcadlin in hippocampal neurons.
• Dual inputs by serotonin and glutamate activate p38 MAP kinase.
• Chronic administration of fluoxetine induces Arcadlin in the hippocampus.
Abstract
The monoamine hypothesis does not fully explain the delayed onset of recovery after antidepressant treatment or the mechanisms of recovery after electroconvulsive therapy (ECT). The common mechanism that operates both in ECT and monoaminergic treatment presumably involves molecules induced in both of these conditions. A spine density modulator, Arcadlin (Acad), the rat orthologue of human Protocadherin-8 (PCDH8) and of Xenopus and zebrafish Paraxial protocadherin (PAPC), is induced by both electroconvulsive seizure (ECS) and antidepressants; however, its cellular mechanism remains elusive. Here we confirm induction of Arcadlin upon stimulation of an N-methyl-d-aspartate (NMDA) receptor in cultured hippocampal neurons. Stimulation of an NMDA receptor also induced acute (20 min) and delayed (2 h) phosphorylation of the p38 mitogen-activated protein (MAP) kinase; the delayed phosphorylation was not obvious in Acad–/– neurons, suggesting that it depends on Arcadlin induction. Exposure of highly mature cultured hippocampal neurons to 1–10 μM serotonin for 4 h resulted in Arcadlin induction and p38 MAP kinase phosphorylation. Co-application of the NMDA receptor antagonist d-(-)-2-amino-5-phosphonopentanoic acid (APV) completely blocked Arcadlin induction and p38 MAP kinase phosphorylation. Finally, administration of antidepressant fluoxetine in mice for 16 days induced Arcadlin expression in the hippocampus. Our data indicate that the Arcadlin-p38 MAP kinase pathway is a candidate neural network modulator that is activated in hippocampal neurons under the dual regulation of serotonin and glutamate and, hence, may play a role in antidepressant therapies.
